Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/21825Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pavlidis, N. | en |
| dc.contributor.author | Kalefezra, J. | en |
| dc.contributor.author | Briassoulis, E. | en |
| dc.contributor.author | Skarlos, D. | en |
| dc.contributor.author | Kosmidis, P. | en |
| dc.contributor.author | Saferiadis, K. | en |
| dc.contributor.author | Bairaktari, E. | en |
| dc.contributor.author | Bafaloukos, D. | en |
| dc.contributor.author | Maravegias, A. | en |
| dc.contributor.author | Theoharis, D. | en |
| dc.contributor.author | Fountzilas, G. | en |
| dc.date.accessioned | 2015-11-24T19:17:55Z | - |
| dc.date.available | 2015-11-24T19:17:55Z | - |
| dc.identifier.issn | 0098-1532 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/21825 | - |
| dc.rights | Default Licence | - |
| dc.subject | carcinoma of unknown primary | en |
| dc.subject | serum tumor markers | en |
| dc.subject | carcinoembryonic antigen | en |
| dc.subject | poorly differentiated carcinoma | en |
| dc.subject | primary site | en |
| dc.subject | follow-up | en |
| dc.subject | serum | en |
| dc.subject | diagnosis | en |
| dc.subject | adenocarcinoma | en |
| dc.subject | malignancies | en |
| dc.subject | lymphoma | en |
| dc.subject | antigen | en |
| dc.subject | cancer | en |
| dc.title | Evaluation of 6 Tumor-Markers in Patients with Carcinoma of Unknown Primary | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | <Go to ISI>://A1994MT07000002 | - |
| heal.identifier.secondary | http://onlinelibrary.wiley.com/doi/10.1002/mpo.2950220303/abstract | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 1994 | - |
| heal.abstract | We have retrospectively evaluated six serum tumor markers in 85 patients with carcinoma of unknown primary. The serum levels of carcinoembryonic antigen (CEA), CA 19-9, CA 15-3, CA 125, beta-chorionic gonadotropin (beta-HCG) and a-fetoprotein (AFP) were related with the histological pattern (undifferentiated carcinoma or adenocarcinoma), the number and the site of metastases, as well as the response to chemotherapy and the patients' survival. More than 40% of the patients had increased serum levels of all six tumor markers, except of AFP which was found to be increased in only 17% of them. Increased levels of CA 19-9 were related to metastatic adenocarcinoma, whereas CA 19-9 and CA 15-3 had a relationship with more advanced disease. Patients with liver involvement had higher mean levels of CEA and CA 19-9 as compared to those with nodal disease. None of these markers was found to have a predictive value for response to chemotherapy or survival. Although the present study has a retrospective nature, it allows us to conclude that patients with CUP have a nonspecific over-expression of the above serum tumor markers and that routine use of these markers does not offer any diagnostic or prognostic assistance. (C) 1994 Wiley-Liss, Inc. | en |
| heal.journalName | Med Pediatr Oncol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
